JENNIFER BUTLER: Open Payments
NPI 1881841047 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,525 in 114 payments from 38 companies in 2025. Trend: 2023 $4,224 · 2024 $2,929 · 2025 $2,525
Food & beverage: $2,509Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $279 |
| ABBVIE INC. | 12 | $247 |
| PFIZER INC. | 8 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $164 |
| Janssen Biotech, Inc. | 8 | $156 |
| Merck Sharp & Dohme LLC | 5 | $152 |
| Eisai Inc. | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| BeOne Medicines USA, Inc. | 4 | $91 |
| GENZYME CORPORATION | 3 | $84 |
Products named: Enhertu, VENCLEXTA, KEYTRUDA, TAGRISSO, Lenvima, EPKINLY, ZEPZELCA, TEVIMBRA.
Industry payments across GA — which companies pay providers there.
